WULF vs XP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
TeraWulf exhibits critical financial instability, highlighted by a Piotroski F-Score of 1/9, indicating severe deterioration in fundamental health. The company's valuation is completely detached from its operational reality, with a Price/Sales ratio of 59.24 and a Forward P/E of 5092.50 despite an operating margin of -210.53%. While analysts maintain a 'strong_buy' rating and historical price action has been explosive, the combination of catastrophic EPS growth (-800% YoY) and significant insider selling by the CEO and CFO suggests a speculative bubble.
XP Inc. exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and financial stability. The stock is significantly undervalued, trading at $19.63, which is slightly below its Graham Number ($20.01) and far below its growth-based intrinsic value ($55.17). While the technical trend is currently bearish and insider sentiment is lukewarm, the combination of a low P/E (10.12), high ROE (23.71%), and consistent earnings growth makes it a compelling value play. The company's ability to maintain high profit margins (29.09%) while growing revenue by 13.3% YoY suggests a strong competitive moat in the capital markets sector.
Compare Another Pair
Related Comparisons
WULF vs XP: Head-to-Head Comparison
This page compares TeraWulf Inc. (WULF) and XP Inc. (XP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.